CALGARY, July 31, 2018 /CNW/ – High Tide Ventures Inc. (“High Tide” or the “Company”) today announced that, as a result of its strong real estate relationships across the country, it recently acquired 50.1% of KushBar Inc., the owner of the “KushBar” brand and retail concept focused on the valued Canadian cannabis consumer. High Tide has included the KushBar brand and concept in several retail cannabis applications submitted to the Alberta Gaming and Liquor Commission (“AGLC”). Including these applications, the Company’s total number currently in process is rapidly approaching the maximum of 37 retail locations across in the province.
TORONTO, July 31, 2018 /CNW/ – High Hampton Holdings Corp. (CSE: HC)(FSE: 0HCN) (“High Hampton” or the “Company”) is pleased to announce, that further to its news release on April 18, 2018, the Company has acquired 100% of all outstanding shares of HS Airway Holding (“CALIGOLD”), a California corporation owning the CALIGOLD Edibles brand (the “Transaction”).
TORONTO, July 12, 2018 /CNW/ – FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE) (OTC: FSDDF) is pleased to announce a binding agreement to purchase 51% of Atlantic Island Cannabis Inc. (to be renamed FSD Atlantic Pharma Inc.) effective July 4, 2018. The agreement involves a strategic investment of $40 million to drive production and sales of legal cannabis in the province of Newfoundland.
TORONTO, July 19, 2018 /PRNewswire/ – FSD Pharma Inc. (“FSD Pharma”) (CSE:HUGE) (OTC:FSDDF) today announced that its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”) has entered into a non-binding memorandum of understanding (“MOU”) with High Tide Ventures Inc. (“High Tide”) dated July 18, 2018 to supply the Saskatchewan market on a wholesale basis with up to 5,000 kilograms of cannabis products over the next year when available. FSD Pharma is working together with Auxly (formerly Cannabis Wheaton Income Corp.) (TSX.V:XLY) to achieve its mission to develop the largest hydroponic indoor cannabis cultivation facility in Cobourg, Ontario, Canada.
QUEBEC CITY, Quebec, July 18, 2018 (GLOBE NEWSWIRE) — NuRAN Wireless Inc. (CSE:NUR) (OTC:NRRWF) (FSE:1RN), a leading supplier of mobile and broadband wireless infrastructure solutions, is conducting a series of trials of the Telecom Infra Project’s (TIP) OpenCellular wireless access platform with Tier-1 mobile network operators (“MNOs”). NuRAN is working in collaboration with Facebook and TIP as an original equipment manufacturer and distributor of OpenCellular.
TORONTO, July 17, 2018 (GLOBE NEWSWIRE) — Canada House Wellness Group Inc. (“Canada House”) or the (“Company”) (CSE:CHV) is pleased to announce that it has entered into, through its wholly owned subsidiary Abba Medix Corp., an exclusive licensing agreement with Medicine Man Technologies Inc. (OTCQB:MDCL) (“Medicine Man”), one of the United States’ leading cannabis branding and consulting companies, for deployment of its intellectual property and product lines (Three a Light ®, Success Nutrients ®, General Intellectual Property) into the Canadian marketplace.
TORONTO, July 16, 2018 /CNW/ – Canntab Therapeutics Limited (CSE:PILL) (“Canntab” or the “Company“), a leader in the development of the cannabis in tablet or capsule form, is pleased to announce that it has engaged Lorne Gertner, one of the world’s foremost investors in the cannabis industry and one of its trailblazing pioneers, as a strategic consultant. Mr. Gertner has significant experience on the boards of a number of publicly traded cannabis companies, including Hiku Brands Company, and has developed a global network of contacts in the cannabis industry along with a deep understanding of retail distribution, both of which Canntab hopes to leverage as it positions itself for expansion into international markets.
TORONTO, July 10, 2018 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (“FSD Pharma“), which, through its wholly-owned subsidiary FV Pharma Inc., is a licensed producer pursuant to the Access to Cannabis for Medical Purposes Regulations, is pleased to announce that it has entered into a non-binding letter of intent (the “LOI“) with Canntab Therapeutics Limited (CSE: PILL) (“Canntab“), a leader in the rapidly growing cannabis pill market. Under the terms of the LOI, FSD Pharma will assist Canntab to obtain a license to process and sell cannabis products pursuant to the Cannabis Act (the “License“), and will provide Canntab with space at its 620,000 square foot facility (the “FSD Facility“), which is located just one hour east of Toronto
Continue Reading “FSD Pharma Announces Collaboration and Profit Sharing Agreement with Canntab for Production and Market of Oral Dose Delivery Platforms”
FSD Pharma Inc. (CSE:HUGE) wants to construct the largest hydroponic indoor cannabis facility in the world
TORONTO, July 3, 2018 /CNW/ – FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE) is pleased to provide an update on the progress of the joint venture between its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma) and Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly”).